In this interview we discuss the goals of therapy in multiple myeloma, treatment combinations and transplantation, and how markers such as minimal residual disease are used.
Faith Davies, MD
Advertisement
Articles by Faith Davies, MD
Advertisement
Latest Updated Articles
Is Molecular Remission the Goal When Treating Myeloma?Published: December 8th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Subcutaneous Toripalimab Meets Primary End Points in Nonsquamous NSCLC
2
Evolutions Across NSCLC, Multiple Myeloma, and AML at Georgia Cancer Center
3
ONCOLOGY Editorial Advisory Board Member Dies from Glioblastoma
4
FDA Approves Updated Cosibelimab Label in Cutaneous Squamous Cell Carcinoma
5
